Disease Overview：Polycystic Ovary Syndrome（PCOS）
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting 6–12% of women of reproductive age. Characterized by chronic anovulation, hyperandrogenism (e.g., hirsutism, acne, alopecia), and polycystic ovarian morphology on ultrasound, PCOS is associated with insulin resistance, metabolic dysfunction, and increased long-term risks of type 2 diabetes, cardiovascular disease, and endometrial hyperplasia. Diagnosis follows the Rotterdam criteria—requiring at least two of: oligo- or anovulation, clinical or biochemical signs of hyperandrogenism, and ultrasonographic evidence of polycystic ovaries—after excluding other etiologies such as congenital adrenal hyperplasia or hyperprolactinemia. Management is individualized and multidisciplinary, encompassing lifestyle modification, pharmacotherapy (e.g., metformin, combined oral contraceptives, ovulation-inducing agents like letrozole or gonadotropins), and, when indicated, assisted reproductive technologies.
China offers distinct advantages for PCOS care: leading endocrinology centers—many affiliated with top-tier academic hospitals—employ evidence-based protocols aligned with international guidelines (ESHRE/ASRM). Advanced imaging (3D transvaginal ultrasound), automated hormone assays, and integrated metabolic profiling support precise phenotyping and longitudinal monitoring. Success rates in restoring ovulation and achieving live birth—particularly in lean and obese subtypes—are consistently reported above global averages in peer-reviewed Chinese cohort studies. Crucially, treatment costs remain 40–60% lower than in the US, UK, or Germany, without compromising quality or safety standards. As a dedicated medical tourism agency, we facilitate seamless access to these resources: vetting JCI-accredited hospitals, coordinating specialist consultations, providing itemized, transparent pricing in advance, and offering end-to-end support—from visa assistance and interpreter services to post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Polycystic Ovary Syndrome (PCOS) — Endocrinology Department
Non-Surgical / Conservative / Medication-Based Management
*Target criteria:* BMI < 35 kg/m², no infertility urgency, mild–moderate hirsutism/acne, preserved ovarian reserve, no contraindications to hormonal therapy.
- •Lifestyle Intervention (First-line)
- Nutritionist consultation (4 sessions): $60–$100 - Baseline labs (fasting glucose, HbA1c, lipid panel, testosterone, SHBG, AMH): $95–$135
- •Pharmacotherapy
- Metformin (500 mg BID, 3-month supply + monitoring): $18–$32 - Spironolactone (50–100 mg/day, 3-month supply + potassium/renal function tests): $22–$38 - Letrozole (for ovulation induction, per cycle, includes ultrasound follicular monitoring ×3): $110–$175
Surgical / Procedural Options
*Eligibility:* Clomiphene/letrozole-resistant anovulation; BMI ≤ 32 kg/m²; normal uterine cavity; no active pelvic infection or coagulopathy.
- •Laparoscopic Ovarian Drilling (LOD)
- LOD procedure (Grade 3A hospital, including anesthesia, OR fee, surgeon fee, 1-night stay): $1,450–$2,100 - Post-op follow-up (day-7 visit + repeat hormone panel): $45–$70
Special / Complex Condition Management
- •PCOS with Severe Insulin Resistance & Prediabetes
- •PCOS + Infertility + Tubal Factor
- •Adolescent PCOS (<18 years)
Quick Selection Guide
- •<25 years, budget-conscious, mild symptoms: Lifestyle + metformin ($140–$420 total first year)
- •25–35 years, infertility priority, moderate BMI: Letrozole cycles + ultrasound monitoring ($330–$525 per ovulation attempt)
- •35+ years, failed medical therapy, BMI 28–32: Laparoscopic ovarian drilling ($1,680–$2,430 all-inclusive)
- •BMI ≥ 35 + T2DM comorbidity: GLP-1 agonist + multidisciplinary metabolic clinic ($1,500–$2,100 first 6 months)
- •Adolescent onset with rapid progression: Pediatric endocrine referral + longitudinal monitoring ($220–$350 initial evaluation)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Polycystic Ovary Syndrome Medical Vacation Packages
Curated transparent all-inclusive packages combining Polycystic Ovary Syndrome treatment with China top medical destinations:
